Punicalagin inhibits the viability, migration, invasion, and EMT by regulating GOLPH3 in breast cancer cells

References

• DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–418.
   PubMed Web of Science ®Google Scholar
• Donepudi MS, Kondapalli K, Amos SJ, et al. Breast cancer statistics and markers. J Cancer Res Ther. 2014;10:506–511.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Synnott NC, Crown J. Mutant p53 in breast cancer: potential as a therapeutic target and biomarker. Breast Cancer Res Treat. 2018;170:213–219.
   PubMed Web of Science ®Google Scholar
• Ngeow J, Sesock K, Eng C. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast Cancer Res Treat. 2017;165:1–8.
   PubMed Web of Science ®Google Scholar
• Araki K, Miyoshi Y. Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer. Breast Cancer. 2018;25:392–401.
   PubMed Web of Science ®Google Scholar
• Shirode AB, Bharali DJ, Nallanthighal S, et al. Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention. Int J Nanomedicine. 2015;10:475–484.
   PubMed Web of Science ®Google Scholar
• Ismail T, Sestili P, Akhtar S. Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. J Ethnopharmacol. 2012;143:397–405.
   PubMed Web of Science ®Google Scholar
• Amri Z, Zaouay F, Lazreg-Aref H, et al. Phytochemical content, fatty acids composition and antioxidant potential of different pomegranate parts: comparison between edible and non-edible varieties grown in Tunisia. Int J Biol Macromol. 2017;104:274–280.
   PubMed Web of Science ®Google Scholar
• Lin LT, Chen TY, Lin SC, et al. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol. 2013;13:187.
   PubMed Web of Science ®Google Scholar
• Anibal PC, Peixoto IT, Foglio MA, et al. Antifungal activity of the ethanolic extracts of Punica granatum L. and evaluation of the morphological and structural modifications of its compounds upon the cells of Candida spp. Braz J Microbiol. 2013;44:839–848.
   PubMed Web of Science ®Google Scholar
• Braga LC, Shupp JW, Cummings C, et al. Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production. J Ethnopharmacol. 2005;96:335–339.
   PubMed Web of Science ®Google Scholar
• Sestili P, Martinelli C, Ricci D, et al. Cytoprotective effect of preparations from various parts of Punica granatum L. fruits in oxidatively injured mammalian cells in comparison with their antioxidant capacity in cell free systems. Pharmacol Res. 2007;56:18–26.
   PubMed Web of Science ®Google Scholar
• Khateeb J, Gantman A, Kreitenberg AJ, et al. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis. 2010;208:119–125.
   PubMed Web of Science ®Google Scholar
• Yao X, Cheng X, Zhang L, et al. Punicalagin from pomegranate promotes human papillary thyroid carcinoma BCPAP cell death by triggering ATM-mediated DNA damage response. Nutr Res. 2017;47:63–71.
   PubMed Web of Science ®Google Scholar
• Adams LS, Seeram NP, Aggarwal BB, et al. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem. 2006;54:980–985.
   PubMed Web of Science ®Google Scholar
• Tang JM, Min J, Li BS, et al. Therapeutic effects of punicalagin against ovarian carcinoma cells in association with beta-catenin signaling inhibition. Int J Gynecol Cancer. 2016;26:1557–1563.
   PubMed Web of Science ®Google Scholar
• Tang J, Li B, Hong S, et al. Punicalagin suppresses the proliferation and invasion of cervical cancer cells through inhibition of the beta-catenin pathway. Mol Med Rep. 2017;16:1439–1444.
   PubMed Web of Science ®Google Scholar
• Huang J, Li H, Ren G. Epithelial–mesenchymal transition and drug resistance in breast cancer. Int J Oncol. 2015;47:840–848.
   PubMed Web of Science ®Google Scholar
• Roxanis I. Occurrence and significance of epithelial–mesenchymal transition in breast cancer. J Clin Pathol. 2013;66:517–521.
   PubMed Web of Science ®Google Scholar
• Yeung KT, Yang J. Epithelial–mesenchymal transition in tumor metastasis. Mol Oncol. 2017;11:28–39.
   PubMed Web of Science ®Google Scholar
• Liao TT, Yang MH. Revisiting epithelial–mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness. Mol Oncol. 2017;11:792–804.
   PubMed Web of Science ®Google Scholar
• Chen YM, Liu Y, Wei HY, et al. Linc-ROR induces epithelial–mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumor Biol. 2016;37:10861–10870.
   PubMedGoogle Scholar
• Mallini P, Lennard T, Kirby J, et al. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev. 2014;40:341–348.
   PubMed Web of Science ®Google Scholar
• Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis. 2008;25:621–628.
   PubMed Web of Science ®Google Scholar
• Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol. 2004;48:463–476.
   PubMed Web of Science ®Google Scholar
• Wu Z, Xue S, Zheng B, et al. Expression and significance of c-kit and epithelial–mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs). J Thorac Dis. 2019;11:4602–4612.
   PubMed Web of Science ®Google Scholar
• Xu X, Yan Q, Wang Y, et al. NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers. Oncol Rep. 2017;37:449–457.
   PubMed Web of Science ®Google Scholar
• Settheetham W, Ishida T. Study of genotoxic effects of antidiarrheal medicinal herbs on human cells in vitro. Southeast Asian J Trop Med Public Health. 1995;26:306–310.
   PubMedGoogle Scholar
• Seeram NP, Adams LS, Henning SM, et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem. 2005;16:360–367.
   PubMed Web of Science ®Google Scholar
• Afaq F, Saleem M, Krueger CG, et al. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer. 2005;113:423–433.
   PubMed Web of Science ®Google Scholar
• Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer Lett. 2008;269:262–268.
   PubMed Web of Science ®Google Scholar
• Chen LG, Huang WT, Lee LT, et al. Ellagitannins from Terminalia calamansanai induced apoptosis in HL-60 cells. Toxicol in Vitro. 2009;23:603–609.
   PubMed Web of Science ®Google Scholar
• Aqil F, Munagala R, Vadhanam MV, et al. Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk. Food Res Int. 2012;49:345–353.
   PubMed Web of Science ®Google Scholar
• Afaq F, Malik A, Syed D, et al. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol. 2005;81:38–45.
   PubMed Web of Science ®Google Scholar
• Afaq F, Khan N, Syed DN, et al. Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Photochem Photobiol. 2010;86:1318–1326.
   PubMed Web of Science ®Google Scholar
• Malik A, Afaq F, Sarfaraz S, et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A. 2005;102:14813–14818.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang F, Zheng W, et al. Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitro. Biomed Pharmacother. 2016;80:227–235.
   PubMed Web of Science ®Google Scholar
• Wu CC, Taylor RS, Lane DR, et al. GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic. 2000;1:963–975.
   PubMed Web of Science ®Google Scholar
• Zhou J, Xu T, Qin R, et al. Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis. J Neurooncol. 2012;110:195–203.
   PubMed Web of Science ®Google Scholar
• Tang S, Yang R, Zhou X, et al. Expression of GOLPH3 in patients with non-small cell lung cancer and xenografts models. Oncol Lett. 2018;15:7555–7562.
   PubMed Web of Science ®Google Scholar
• Liu J, Wei H, Lai L, et al. Golgi phosphoprotein-3 promotes invasiveness of gastric cancer cells through the mTOR signalling pathway. CIM. 2019;42:E38–E47.
   Google Scholar
• Wen Y, Tan X, Wu X, et al. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial–mesenchymal transition. Cancer Biomark. 2019;26:21–30.
   PubMed Web of Science ®Google Scholar